Healthtech presents opportunity regardless of sector specialism
Private equity firms without a special focus on the healthcare market can still find plenty of opportunities to invest in the healthcare technology space, according to Josef Fuss and Shenell Page (pictured) of Taylor Wessing
More on Healthcare
VCs invest £14m in Storm Therapeutics
Storm Therapeutics has now raised more than £30m in capital from its new and existing investors
Syncona leads £35m series-A for Quell
UCL Technology Fund also took part in the round for the newly launched cell therapy company
BIVF, UCB Ventures lead £1.4m round for Rinri
Representatives from BIVF, UCB Ventures and BioCity have joined the company's board of directors
LSP et al. back $38.5m series-B for DNA Script
Illumina Ventures, M Ventures, Sofinnova, Kurma and Idinvest recommit to DNA Script
Latest News
One Peak Partners et al. invest €15m in Quentic
One Peak Partners and Morgan Stanley Expansion Capital invested €22m in Quentic in 2017
Charme Capital exits Atop in €380m deal
Sale ends a two-year holding period for Charme, which acquired the company via its third fund
Horizon-backed Wireless Innovation bolts on Ground Control
GP provides equity to support the acquisition of the US-based telecommunications firm
USS appoints new CEO of investments
Simon Pilcher will be responsible for overseeing the investment strategy governing the scheme's £64bn in assets